These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 2174292

  • 1. The effect of leukotriene B4, leukotriene C4, zymosan activated serum, histamine, tabanid extract and N-formyl-methionyl-leucyl-phenylalanine on the in vitro migration of equine eosinophils.
    McEwen BJ, Wilcock BP, Eyre P.
    Can J Vet Res; 1990 Oct; 54(4):400-4. PubMed ID: 2174292
    [Abstract] [Full Text] [Related]

  • 2. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA, Casale TB.
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):65-70. PubMed ID: 7811471
    [Abstract] [Full Text] [Related]

  • 3. Various authentic chemoattractants mediating leukocyte adherence inhibition.
    Thomson DM.
    J Natl Cancer Inst; 1984 Sep; 73(3):595-605. PubMed ID: 6088878
    [Abstract] [Full Text] [Related]

  • 4. Modulation of the heterogeneous membrane potential response of neutrophils to N-formyl-methionyl-leucyl-phenylalanine (FMLP) by leukotriene B4: evidence for cell recruitment.
    Fletcher MP.
    J Immunol; 1986 Jun 01; 136(11):4213-9. PubMed ID: 3009618
    [Abstract] [Full Text] [Related]

  • 5. Release of leukotriene B4 from human neutrophils and its relationship to degranulation induced by N-formyl-methionyl-leucyl-phenylalanine, serum-treated zymosan and the ionophore A23187.
    Palmer RM, Salmon JA.
    Immunology; 1983 Sep 01; 50(1):65-73. PubMed ID: 6309653
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of neutrophil and eosinophil induced chemotaxis by nedocromil sodium and sodium cromoglycate.
    Bruijnzeel PL, Warringa RA, Kok PT, Kreukniet J.
    Br J Pharmacol; 1990 Apr 01; 99(4):798-802. PubMed ID: 2163279
    [Abstract] [Full Text] [Related]

  • 7. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan.
    Bruynzeel PL, Kok PT, Hamelink ML, Kijne AM, Verhagen J.
    FEBS Lett; 1985 Sep 23; 189(2):350-4. PubMed ID: 2995125
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW, Enkel H, Gifford LA, Chenoweth DE, Rosenbaum JT.
    J Immunol; 1986 Sep 15; 137(6):1971-6. PubMed ID: 3018083
    [Abstract] [Full Text] [Related]

  • 9. Generation of leukotrienes by human monocytes pretreated with cytochalasin B and stimulated with formyl-methionyl-leucyl-phenylalanine.
    Williams JD, Robin JL, Lewis RA, Lee TH, Austen KF.
    J Immunol; 1986 Jan 15; 136(2):642-8. PubMed ID: 3001181
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB.
    J Clin Invest; 1986 Dec 15; 78(6):1701-6. PubMed ID: 3023451
    [Abstract] [Full Text] [Related]

  • 11. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism.
    Muñoz NM, Douglas I, Mayer D, Herrnreiter A, Zhu X, Leff AR.
    Am J Respir Crit Care Med; 1997 Apr 15; 155(4):1398-403. PubMed ID: 9105085
    [Abstract] [Full Text] [Related]

  • 12. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T, Yamamura H, Kohno S.
    Arzneimittelforschung; 1997 Oct 15; 47(10):1112-6. PubMed ID: 9368704
    [Abstract] [Full Text] [Related]

  • 13. Effects of novel lipoxygenase products on migration of eosinophils and neutrophils in vitro.
    Udén AM, Palmblad J, Lindgren JA, Malmsten C.
    Int Arch Allergy Appl Immunol; 1983 Oct 15; 72(1):91-3. PubMed ID: 6307891
    [Abstract] [Full Text] [Related]

  • 14. Influence of chemotactic agents on the locomotion of equine polymorphonuclear and mononuclear leucocytes.
    Sedgwick AD, Dawson J, Lees P.
    Res Vet Sci; 1987 Jul 15; 43(1):55-8. PubMed ID: 3628984
    [Abstract] [Full Text] [Related]

  • 15. Chemotaxis of radiolabeled equine neutrophils.
    Camp CJ, Leid RW.
    Am J Vet Res; 1982 Mar 15; 43(3):397-401. PubMed ID: 7073055
    [Abstract] [Full Text] [Related]

  • 16. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
    Thomson DM.
    J Natl Cancer Inst; 1984 Sep 15; 73(3):607-16. PubMed ID: 6088879
    [Abstract] [Full Text] [Related]

  • 17. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
    Tsai BS, Keith RH, Villani-Price D, Haack RA, Djuric SW.
    J Pharmacol Exp Ther; 1994 Mar 15; 268(3):1493-8. PubMed ID: 8138959
    [Abstract] [Full Text] [Related]

  • 18. Eosinophils recruited to the lung by segmental antigen challenge show a reduced chemotactic response to leukotriene B4.
    Kim CJ, Kane GC, Zangrilli JG, Cho SK, Koh YY, Peters SP.
    Prostaglandins; 1994 May 15; 47(5):393-403. PubMed ID: 8066187
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.
    Taylor BM, Czuk CI, Brunden MN, Wishka DG, Morris J, Sun FF.
    Adv Prostaglandin Thromboxane Leukot Res; 1989 May 15; 19():195-8. PubMed ID: 2546384
    [No Abstract] [Full Text] [Related]

  • 20. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro.
    Hidi R, Coëffier E, Vargaftig BB.
    J Leukoc Biol; 1992 May 15; 51(5):425-31. PubMed ID: 1318347
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.